Inhibiting the peripheral voltage-gated sodium channel Na v 1.8 may be a way to manage pain with little to no risk of ...
Migraine Again on MSN
Could this new pain drug provide migraine relief? What to know about suzetrigine (Journavx)
Can suzetrigine (Journavx) help with migraine pain? Learn how this new nonopioid pain drug works off-label, what the research ...
A new study adds to evidence which suggests treating breast cancer patients with sodium channel blockers could be a promising future treatment to prevent the spread of cancer during the gap between ...
South Korea’s SK Biopharmaceuticals Co. Ltd. and Shanghai-based Ignis Therapeutic Co. Ltd. signed a ₩804 billion (US$58 million) licensing deal on April 18, granting the latter global rights to a ...
Nat Clin Pract Neurol. 2008;4(3):159-169. Drug Primary clinical use Protective effect during administration in animal models? Effects of withdrawal in EAE Clinical study Phenytoin Treatment of ...
PHILADELPHIA -- An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.
Psoriasis, a common chronic immune-mediated inflammatory skin disorder, is characterized by excessive proliferation and abnormal differentiation of keratinocytes and dermal infiltration of immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results